McKesson, CD&R Near Deal to Acquire Option Care Health

The structure is the story here: a 51/49 split with a future buyout right effectively hands McKesson a path to full ownership while keeping the asset off its balance sheet for now, a common private-equity construct for consolidating care-delivery assets. It matters because the largest independent US infusion provider would move under a distributor-plus-PE umbrella, further concentrating home and alternate-site care. The open question is whether the deal closes as reported or the talks lapse, and whether that future call right shapes how Option Care is run in the interim.